Italy
Glenmark Life Sciences Ltd (BOM:543322) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth Amid Margin Pressures
Revenue from Operations: INR588 crores, up 9.7% quarter on quarter.Gross Profit: INR301 crores at 51.1%, down from 55.5% in Q4 FY24.EBITDA: INR165 crores, up 1